title: Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure.
authors.forename: Ramin
authors.initials: R
authors.lastname: Lotfi
authors.forename: Peter
authors.initials: P
authors.lastname: Moeller
authors.forename: Mathias
authors.initials: M
authors.lastname: Schmid
authors.forename: Hubert
authors.initials: H
authors.lastname: Schrezenmeier
mesh_terms: D000741:Anemia, Aplastic / Q000150:complications* / Q000628:therapy*; D005260:Female; D006470:Hemorrhage / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D017713:Platelet Transfusion; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects* / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D013926:Thrombopoietin / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim